New clinical professor aims to make radiotherapy more precise and less harmful
Camilla Kronborg takes up her position as Clinical Professor of Oncology at the Department of Clinical Medicine on 1 September 2026. Her research focuses on how more targeted radiotherapy can reduce long-term side effects for patients.
As Clinical Professor, Camilla Kronborg will strengthen clinical research into radiotherapy at the Danish Centre for Particle Therapy at Aarhus University Hospital. Her research focuses particularly on cancers in the pelvic region and on re-irradiation of patients whose cancer has recurred in an area previously treated with radiotherapy.
“My aim is to enable more patients to receive effective treatment with fewer long-term side effects. The professorship gives me a strong platform for developing clinical research, strengthening the link between research and clinical practice, and translating new knowledge into better treatment for patients,” says Camilla Kronborg.
The new professor’s research focuses particularly on proton therapy, in which the radiation can be targeted so that healthy tissue surrounding a tumour is exposed to less radiation than with conventional radiotherapy.
“It is important to select patients carefully so that those who stand to benefit the most are offered the treatment. We are currently investigating this for rectal cancer, anal cancer and cervical cancer, among others,” says Camilla Kronborg.
Professor Kronborg leads the national ReRad II and ReRad III studies, which are investigating re-irradiation with proton therapy for recurrent rectal and anal cancer. She is also involved in projects on the long-term effects of radiotherapy, including how treatment affects sexual health, as well as the bones and bowel.
Contact
Clinical Professor and Consultant Camilla Kronborg
Aarhus University, Department of Clinical Medicine, and
Aarhus University Hospital, Danish Centre for Particle Therapy
Telephone: +45 26 71 67 76
Email: camkro@clin.au.dk